Nibourel O, Guihard S, Roumier C, Pottier Letter, Terre C, Paquet Good, Peyrouze P, Geffroy S, Quentin S, Alberdi An effective, Abdelali RB, Renneville An excellent, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok MH. Copy-number studies known this new prognostic ;31(3):555-564.
Mohamed Am, Balsat M, Koering C, Maucort-Boulch D, Boissel N, Payen-Homosexual L, Cheok Yards, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud We, Hayette S, Dumontet C, Cros Elizabeth, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet M, Ceraulo An excellent, Mortreux F, Wattel Elizabeth. Leuk Res. 2017;-28.
Mishima Y, Paiva B, Shi J, Playground J, Manier S, Takagi S, Massoud M, Perilla-Glen A good, Aljawai Y, Huynh D, Roccaro Have always been, Sacco A beneficial, Capelletti M, Detappe A, Alignani D, Anderson KC, Munshi NC, Do well F, Lohr JG, Ha Grams, Freeman SS, Van Allen EM, Adalsteinsson Va, Michor F, San Miguel JF, Ghobrial Im. 2017;19(1):218-224.
Minnema MC, Kimby Elizabeth, DSa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis Elizabeth, Kremer S, Fitsiori Good, Simon L, Davi F, Lunn Yards, Castillo JJ, Patterson CJ, Ce Garff-Tavernier Yards, Costopoulos Yards, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP. Rule into medical diagnosis, procedures and you will response conditions getting Bing-Neel problem. Haematologica. 2017;102(1):43-51.
Micol JB, Pastore Good, Inoue D, Duployez N, Kim Age, Lee South carolina, Durham BH, Chung Year, Cho H, Zhang XJ, Yoshimi Good, Krivtsov A good, Koche R, Solary Elizabeth, Sinha A good, Preudhomme C, Abdel-Wahab O. ASXL2 is essential having haematopoiesis and you will acts as a beneficial haploinsufficient tumour suppressor in leukemia. Nat Commun. 2017;8:15429.
Phone Associate
Meunier M, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet Yards, Wang Y, Faure P, Szymanski Grams, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Playground S. Activated fresh air kinds levels manage NF-kappaB activation because of the reduced amount deferasirox in the erythroid progenitors out-of low chance myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524.
Manier S, Salem KZ, Park J, Landau Weil, Getz G, Ghobrial Im. Genomic difficulty off multiple myeloma as well as systematic ramifications. Nat Rev Clin Oncol. 2017;14(2):100-113.
Manier S, Vitality JT, Sacco An excellent, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta Yards, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro Have always been, Daley GQ, Ghobrial Im. The brand new LIN28B/let-seven axis try a novel healing pathway into the multiple myeloma. Leukemia. 2017;31(4):853-860.
Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco A good, Roccaro In the morning, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller Age, Trippa L, Ghobrial I am. Prognostic part from releasing exosomal miRNAs when you look at the multiple myeloma. Bloodstream. 2017;129(17):2429-2436.
TET2 exon 2 bypassing was a separate beneficial prognostic foundation to own cytogenetically typical acute myelogenous leukemia (AML): TET2 exon dos bypassing inside AML
Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brownish Ce, Gray Letter, Bradner J, Whitesell L, Porco JA, Jr., Ghobrial Im. Inhibiting this new oncogenic interpretation program is an efficient healing method into the several myeloma. Sci Transl Med. 2017;9(389).
Magnez R, Thiroux B, Taront S, Segaoula Z, Quesnel B, Thuru X. PD-1/PD-L1 joining training playing with microscale thermophoresis. Sci Agent. 2017;7(1):17623.
Lacombe F, Campos L, Allou K, Arnoulet C, Delabarthe A great, Dumezy F, Feuillard J, Genevieve F, Guerin E, Boy J, Jouault H, Lepelley P, Maynadie Yards, Solly F, Ballon OW, Preudhomme C, Baruchel An excellent, Dombret H, Ifrah Letter, Bene MC. Prognostic property value multicenter circulate cytometry harmonized investigations off limited residual problem into the severe myeloblastic leukemia. https://datingranking.net/pl/be2-recenzja/ Hematol Oncol. 2017.
